Dianthus Therapeutics, Inc.

DNTH·NASDAQ·$87.48Share Price as of 11/2·$5BMarket Cap as of 11/2

Financials

10-QQ2 ended 06/30/2608/04/26 10-QQ1 ended 03/31/2605/05/26 10-KFY 202503/09/26 10-QQ3 ended 09/30/2511/05/25 10-QQ2 ended 06/30/2508/07/25

Disclosures

8-KCurrent report08/04/26 8-KCurrent report06/12/26 8-KCurrent report05/22/26 8-KCurrent report05/05/26 8-KCurrent report03/26/26

Prospectuses and Registrations

S-3ASRAutomatic shelf registration09/18/26 424B5Prospectus supplement03/11/26 S-3MEFProspectus / registration03/10/26 424B5Prospectus supplement03/09/26 S-8Registration of securities for employees03/09/26

Proxies

DEF 14ADefinitive proxy04/09/26 DEFA14AAdditional proxy materials04/09/26 DEF 14ADefinitive proxy04/10/25 DEFA14AAdditional proxy materials04/10/25 DEF 14ADefinitive proxy04/11/24

Ownership

Form 4Insider transaction09/18/26 144Proposed sale of securities09/17/26 Form 4Insider transaction09/03/26 144Proposed sale of securities09/01/26 Form 4Insider transaction08/19/26

Other

ARSAnnual report to shareholders04/09/26 EFFECTRequest for effectiveness01/30/26 CORRESPCorrespondence with the SEC01/29/26 UPLOADLetter from the SEC01/29/26 ARSAnnual report to shareholders04/10/25